U.S. President Donald Trump said on Monday trade talks with China had gone very well and hinted that a deal has been reached to resolve issues the U.S. has over TikTok ownership. ...

Core Viewpoint - MEG Energy has urged its shareholders to reject the enhanced takeover bid from Strathcona Resources and has reaffirmed its support for a sale to Cenovus [1] Group 1: Company Actions - MEG Energy is advocating for shareholders to reject the takeover offer from its majority stakeholder, Strathcona Resources [1] - The company has expressed continued support for a sale to Cenovus, indicating a preference for this transaction over the Strathcona bid [1] Group 2: Stakeholder Dynamics - Strathcona Resources has made a sweetened takeover bid for MEG Energy, which the company is advising shareholders to reject [1] - The situation highlights the competitive dynamics between Strathcona Resources and Cenovus in the context of MEG Energy's potential sale [1]

Group 1 - California Resources is acquiring Berry Corp in an all-stock deal valued at approximately $717 million, including debt [1] - The acquisition reflects California Resources' strategy to expand its portfolio in the oil production sector [1] - The deal signifies a consolidation trend within the U.S. energy industry, particularly among smaller oil producers [1] Group 2 - The transaction highlights the ongoing interest in mergers and acquisitions as companies seek to enhance operational efficiencies and market presence [1] - The valuation of Berry Corp at $717 million indicates a significant investment in the current energy market [1] - This acquisition may lead to potential synergies and cost savings for California Resources, enhancing its competitive position [1]

aTyr Pharma said on Monday its experimental drug had failed to meet the main goal in a late-stage study testing it in patients with a type of lung disease known as pulmonary sarcoidosis, a disease imp... ...

The Swedish government will in its upcoming budget bill for 2026 increase funds for the armed forces by 26.6 billion crowns ($2.87 billion), Prime Minister Ulf Kristersson said on Monday. ...

AstraZeneca shares fell as much as 3.4% on Monday, their steepest drop since May, after Handelsbanken cut its rating on the drugmaker and Reuters reported the company had paused a major investment in its home market. ...

Swiss drugmaker Novartis and drug developer Monte Rosa Therapeutics signed a licensing deal worth up to $5.7 billion on Monday to develop drugs for immune-mediated diseases. ...

Hours after his company's merger with Paramount closed in August, CEO David Ellison's empire-building kicked into gear. ...

EchoStar said on Monday it expects to hold $24.1 billion in total cash after using proceeds from its spectrum license sales to repay debt, bolstering its balance sheet and supporting growth in wireless, satellite and technology sectors. ...

What matters in U.S. and global markets today ...